Healthcare: Big Biotech Is Bustling with Buy-outs

Industry Focus

The Motley Fool

Interview, Money, Consumergoods, Business, Businessnews, Ceo, Technology, Investing, Stocks, Energy, Fool, Financial, Economy, Healthcare, News, Banking, Motley, Tech, Business News, Investments

4.6 • 854 Ratings

🗓️ 24 January 2018

⏱️ 24 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Celgene consolidates CAR-T and Sanofi hooks-up in hemophilia. Plus: What’s up with Johnson & Johnson’s post-earnings slide?

Transcript

Click on a timestamp to play from that location

0:00.0	Support for Industry Focus comes from our friends Rocket Mortgage by Quicken Loans.
0:03.6	You're confident when it comes to your work and life.
0:05.8	Rocket Mortgage gives you that same confidence when it comes to refinancing your existing mortgage
0:10.0	or buying a home.
0:11.2	It lets you understand all the details so you can be confident that you're
0:14.0	getting the right mortgage for you. Go to rocket mortgage.com slash fool.
0:20.3	Welcome to Industry Focus, the podcast that dives into a different sector of the stock market every day.
0:24.5	It's Wednesday, January 24th.
0:26.5	I'm your host Christine Harjus and I'm joined via Skype by healthcare specialist Todd Campbell.
0:30.7	Todd, hey, how are you? Hi Christine, how are you today?
0:34.0	I am doing great.
0:36.0	Awesome, well we have a power-packed show of M&A to talk about, right?
0:41.0	Yes, so Monday was extremely exciting in the world of health care
0:45.3	M&A, mergers and acquisitions. A rumor that we covered in detail on last Wednesday's show of a deal in the
0:51.9	making between cell gene and Juno therapeutics came to fruition
0:55.8	on Monday. Sel Jean will buy Juno for $87 per share in cash for a total of $9 billion.
1:02.7	And we're not going to dwell on it because we did talk about it
1:05.1	quite a bit on Monday.
1:07.6	But the deal has now been approved by both boards.
1:09.7	It's expected to close this quarter.
1:11.8	Interestingly, there was a 91% premium to the pre-buy-out
1:16.6	rumor levels of Juno's share price. Todd, were you surprised by the price tag?
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.